Modifi Biosciences, Inc.
Biotechnology company · New Haven, Connecticut, United States
Modifi Biosciences, Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2021. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $995,503 sold in a notice filed in 2024.
Modifi Biosciences at a glance
What does Modifi Biosciences do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2022 to 2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $995,503 sold (2024).
Frequently asked questions about Modifi Biosciences
Where is Modifi Biosciences headquartered?
Modifi Biosciences, Inc. is headquartered in New Haven, Connecticut, United States.
What does Modifi Biosciences do?
Modifi Biosciences, Inc. is a biotechnology company.
When was Modifi Biosciences founded?
The earliest incorporation on record for Modifi Biosciences, Inc. is in 2021, according to public company registers.
Similar companies
- Allyx Therapeutics, Inc.New Haven, Connecticut, United States
- Invivyd, Inc.New Haven, Connecticut, United States
- ReNetX Bio, Inc.New Haven, Connecticut, United States
- AtlasXomics Inc.New Haven, Connecticut, United States
- Vion Pharmaceuticals IncNew Haven, Connecticut, United States
- ProteoWise Inc.New Haven, Connecticut, United States
- Oui Therapeutics IncNew Haven, Connecticut, United States
- Cybrexa, Inc.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences